JP2001270980A - Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment - Google Patents
Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipmentInfo
- Publication number
- JP2001270980A JP2001270980A JP2000083984A JP2000083984A JP2001270980A JP 2001270980 A JP2001270980 A JP 2001270980A JP 2000083984 A JP2000083984 A JP 2000083984A JP 2000083984 A JP2000083984 A JP 2000083984A JP 2001270980 A JP2001270980 A JP 2001270980A
- Authority
- JP
- Japan
- Prior art keywords
- polycarbonate resin
- resin composition
- group
- bis
- undecane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004431 polycarbonate resin Substances 0.000 title claims abstract description 50
- 229920005668 polycarbonate resin Polymers 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 230000005865 ionizing radiation Effects 0.000 title abstract description 17
- -1 acetal compound Chemical class 0.000 claims abstract description 55
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 21
- 125000002252 acyl group Chemical group 0.000 claims abstract description 5
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 abstract description 10
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 10
- 230000006866 deterioration Effects 0.000 abstract description 5
- 150000002430 hydrocarbons Chemical group 0.000 abstract description 5
- 238000004383 yellowing Methods 0.000 abstract description 5
- 125000000217 alkyl group Chemical group 0.000 abstract description 4
- 239000004215 Carbon black (E152) Substances 0.000 abstract description 3
- 229930195733 hydrocarbon Natural products 0.000 abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 abstract description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical group C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 8
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 5
- SJMYQUDYIWOWRH-UHFFFAOYSA-N CC1=CC(=CC=C1)C2OCC3(CO2)COC(OC3)C4=CC=CC(=C4)C Chemical compound CC1=CC(=CC=C1)C2OCC3(CO2)COC(OC3)C4=CC=CC(=C4)C SJMYQUDYIWOWRH-UHFFFAOYSA-N 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- AAWOLGHXXOFSJI-UHFFFAOYSA-N 3,9-bis(4-phenylphenyl)-2,4,8,10-tetraoxaspiro[5.5]undecane Chemical compound C1OC(C=2C=CC(=CC=2)C=2C=CC=CC=2)OCC1(CO1)COC1C(C=C1)=CC=C1C1=CC=CC=C1 AAWOLGHXXOFSJI-UHFFFAOYSA-N 0.000 description 3
- YYDPXJIANXUFNV-UHFFFAOYSA-N CC1=CC(=C(C=C1)C2OCC3(CO2)COC(OC3)C4=C(C=C(C=C4)C)C)C Chemical compound CC1=CC(=C(C=C1)C2OCC3(CO2)COC(OC3)C4=C(C=C(C=C4)C)C)C YYDPXJIANXUFNV-UHFFFAOYSA-N 0.000 description 3
- 239000003377 acid catalyst Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 239000002685 polymerization catalyst Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 2
- QLJRDJLTWGHJSN-UHFFFAOYSA-N 3,9-bis(4-methylphenyl)-2,4,8,10-tetraoxaspiro[5.5]undecane Chemical compound C1=CC(C)=CC=C1C1OCC2(COC(OC2)C=2C=CC(C)=CC=2)CO1 QLJRDJLTWGHJSN-UHFFFAOYSA-N 0.000 description 2
- DZQLZCHEALBORZ-UHFFFAOYSA-N 3,9-diphenyl-2,4,8,10-tetraoxaspiro[5.5]undecane Chemical compound C1OC(C=2C=CC=CC=2)OCC1(CO1)COC1C1=CC=CC=C1 DZQLZCHEALBORZ-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- IPFUDSLOIXODCD-UHFFFAOYSA-N CC(C)CC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)CC(C)C Chemical compound CC(C)CC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)CC(C)C IPFUDSLOIXODCD-UHFFFAOYSA-N 0.000 description 2
- ZWMXCMUMCXFIPX-UHFFFAOYSA-N CC1=CC(=C(C=C1)C)C2OCC3(CO2)COC(OC3)C4=C(C=CC(=C4)C)C Chemical compound CC1=CC(=C(C=C1)C)C2OCC3(CO2)COC(OC3)C4=C(C=CC(=C4)C)C ZWMXCMUMCXFIPX-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 238000012696 Interfacial polycondensation Methods 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000003063 flame retardant Substances 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- GPFJHNSSBHPYJK-UHFFFAOYSA-N (3-methylphenyl) hydrogen carbonate Chemical compound CC1=CC=CC(OC(O)=O)=C1 GPFJHNSSBHPYJK-UHFFFAOYSA-N 0.000 description 1
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- MAQOZOILPAMFSW-UHFFFAOYSA-N 2,6-bis[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=C(CC=3C(=CC=C(C)C=3)O)C=C(C)C=2)O)=C1 MAQOZOILPAMFSW-UHFFFAOYSA-N 0.000 description 1
- NFAOATPOYUWEHM-UHFFFAOYSA-N 2-(6-methylheptyl)phenol Chemical compound CC(C)CCCCCC1=CC=CC=C1O NFAOATPOYUWEHM-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- QBTHTNCUNBHSHN-UHFFFAOYSA-N 2-[3,5-bis(2-hydroxyphenyl)phenyl]phenol Chemical compound OC1=CC=CC=C1C1=CC(C=2C(=CC=CC=2)O)=CC(C=2C(=CC=CC=2)O)=C1 QBTHTNCUNBHSHN-UHFFFAOYSA-N 0.000 description 1
- WKVWOPDUENJKAR-UHFFFAOYSA-N 2-cyclohexyl-4-[2-(3-cyclohexyl-4-hydroxyphenyl)propan-2-yl]phenol Chemical compound C=1C=C(O)C(C2CCCCC2)=CC=1C(C)(C)C(C=1)=CC=C(O)C=1C1CCCCC1 WKVWOPDUENJKAR-UHFFFAOYSA-N 0.000 description 1
- ZDRSNHRWLQQICP-UHFFFAOYSA-N 2-tert-butyl-4-[2-(3-tert-butyl-4-hydroxyphenyl)propan-2-yl]phenol Chemical compound C1=C(O)C(C(C)(C)C)=CC(C(C)(C)C=2C=C(C(O)=CC=2)C(C)(C)C)=C1 ZDRSNHRWLQQICP-UHFFFAOYSA-N 0.000 description 1
- VEORPZCZECFIRK-UHFFFAOYSA-N 3,3',5,5'-tetrabromobisphenol A Chemical compound C=1C(Br)=C(O)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(O)C(Br)=C1 VEORPZCZECFIRK-UHFFFAOYSA-N 0.000 description 1
- YMTYZTXUZLQUSF-UHFFFAOYSA-N 3,3'-Dimethylbisphenol A Chemical compound C1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=CC=2)=C1 YMTYZTXUZLQUSF-UHFFFAOYSA-N 0.000 description 1
- CKNCVRMXCLUOJI-UHFFFAOYSA-N 3,3'-dibromobisphenol A Chemical compound C=1C=C(O)C(Br)=CC=1C(C)(C)C1=CC=C(O)C(Br)=C1 CKNCVRMXCLUOJI-UHFFFAOYSA-N 0.000 description 1
- YBYZPHNWHMGCTN-UHFFFAOYSA-N 3,9-bis(4-butoxyphenyl)-2,4,8,10-tetraoxaspiro[5.5]undecane Chemical compound C1=CC(OCCCC)=CC=C1C1OCC2(COC(OC2)C=2C=CC(OCCCC)=CC=2)CO1 YBYZPHNWHMGCTN-UHFFFAOYSA-N 0.000 description 1
- MTUDPVMDYSZROV-UHFFFAOYSA-N 3,9-bis(4-methoxyphenyl)-2,4,8,10-tetraoxaspiro[5.5]undecane Chemical compound C1=CC(OC)=CC=C1C1OCC2(COC(OC2)C=2C=CC(OC)=CC=2)CO1 MTUDPVMDYSZROV-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- VWGKEVWFBOUAND-UHFFFAOYSA-N 4,4'-thiodiphenol Chemical compound C1=CC(O)=CC=C1SC1=CC=C(O)C=C1 VWGKEVWFBOUAND-UHFFFAOYSA-N 0.000 description 1
- NZGQHKSLKRFZFL-UHFFFAOYSA-N 4-(4-hydroxyphenoxy)phenol Chemical compound C1=CC(O)=CC=C1OC1=CC=C(O)C=C1 NZGQHKSLKRFZFL-UHFFFAOYSA-N 0.000 description 1
- RQCACQIALULDSK-UHFFFAOYSA-N 4-(4-hydroxyphenyl)sulfinylphenol Chemical compound C1=CC(O)=CC=C1S(=O)C1=CC=C(O)C=C1 RQCACQIALULDSK-UHFFFAOYSA-N 0.000 description 1
- BATCUENAARTUKW-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-diphenylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BATCUENAARTUKW-UHFFFAOYSA-N 0.000 description 1
- RSSGMIIGVQRGDS-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-phenylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)C1=CC=CC=C1 RSSGMIIGVQRGDS-UHFFFAOYSA-N 0.000 description 1
- BRPSWMCDEYMRPE-UHFFFAOYSA-N 4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol Chemical compound C=1C=C(O)C=CC=1C(C=1C=CC(O)=CC=1)(C)C1=CC=C(O)C=C1 BRPSWMCDEYMRPE-UHFFFAOYSA-N 0.000 description 1
- UMPGNGRIGSEMTC-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)-3,3,5-trimethylcyclohexyl]phenol Chemical compound C1C(C)CC(C)(C)CC1(C=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UMPGNGRIGSEMTC-UHFFFAOYSA-N 0.000 description 1
- OVVCSFQRAXVPGT-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)cyclopentyl]phenol Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCC1 OVVCSFQRAXVPGT-UHFFFAOYSA-N 0.000 description 1
- OKWDECPYZNNVPP-UHFFFAOYSA-N 4-[1-[4-[2-(4-hydroxyphenyl)propyl]phenyl]propan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)CC(C=C1)=CC=C1CC(C)C1=CC=C(O)C=C1 OKWDECPYZNNVPP-UHFFFAOYSA-N 0.000 description 1
- KJMVGAOYRRKQPY-UHFFFAOYSA-N 4-[2,4,6-tri(propan-2-yl)phenyl]phenol Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=C(O)C=C1 KJMVGAOYRRKQPY-UHFFFAOYSA-N 0.000 description 1
- NEOADHINJHPAQK-UHFFFAOYSA-N 4-[2,6-bis(4-hydroxyphenyl)-2,6-dimethylhept-3-en-4-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)(C)CC(C=1C=CC(O)=CC=1)=CC(C)(C)C1=CC=C(O)C=C1 NEOADHINJHPAQK-UHFFFAOYSA-N 0.000 description 1
- ODJUOZPKKHIEOZ-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethylphenyl)propan-2-yl]-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=C(C)C=2)=C1 ODJUOZPKKHIEOZ-UHFFFAOYSA-N 0.000 description 1
- BKTRENAPTCBBFA-UHFFFAOYSA-N 4-[2-(4-hydroxy-3-phenylphenyl)propan-2-yl]-2-phenylphenol Chemical compound C=1C=C(O)C(C=2C=CC=CC=2)=CC=1C(C)(C)C(C=1)=CC=C(O)C=1C1=CC=CC=C1 BKTRENAPTCBBFA-UHFFFAOYSA-N 0.000 description 1
- QHJPJZROUNGTRJ-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)octan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)(CCCCCC)C1=CC=C(O)C=C1 QHJPJZROUNGTRJ-UHFFFAOYSA-N 0.000 description 1
- FFPGPOGKMNQYGP-UHFFFAOYSA-N 4-[3-(4-hydroxyphenoxy)indol-3-yl]oxyphenol Chemical compound C1=CC(O)=CC=C1OC1(OC=2C=CC(O)=CC=2)C2=CC=CC=C2N=C1 FFPGPOGKMNQYGP-UHFFFAOYSA-N 0.000 description 1
- MIJYTDQAOVQRRT-UHFFFAOYSA-N 4-[4,6-bis(4-hydroxyphenyl)-4,6-dimethylhept-2-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)=CC(C)(C=1C=CC(O)=CC=1)CC(C)(C)C1=CC=C(O)C=C1 MIJYTDQAOVQRRT-UHFFFAOYSA-N 0.000 description 1
- NUDSREQIJYWLRA-UHFFFAOYSA-N 4-[9-(4-hydroxy-3-methylphenyl)fluoren-9-yl]-2-methylphenol Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3C3=CC=CC=C32)C=2C=C(C)C(O)=CC=2)=C1 NUDSREQIJYWLRA-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- QHPQWRBYOIRBIT-UHFFFAOYSA-N 4-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C=C1 QHPQWRBYOIRBIT-UHFFFAOYSA-N 0.000 description 1
- SLHDHTKGGYUTPG-UHFFFAOYSA-N 5,7-dichloro-1h-indole-2,3-dione;phenol Chemical compound OC1=CC=CC=C1.OC1=CC=CC=C1.ClC1=CC(Cl)=CC2=C1NC(=O)C2=O SLHDHTKGGYUTPG-UHFFFAOYSA-N 0.000 description 1
- PAJCMEMWFLCNLL-UHFFFAOYSA-N 5-bromo-1h-indole-2,3-dione;phenol Chemical compound OC1=CC=CC=C1.OC1=CC=CC=C1.BrC1=CC=C2NC(=O)C(=O)C2=C1 PAJCMEMWFLCNLL-UHFFFAOYSA-N 0.000 description 1
- GTRAJYAKFCHEKL-UHFFFAOYSA-N 5-chloro-1h-indole-2,3-dione;phenol Chemical compound OC1=CC=CC=C1.OC1=CC=CC=C1.ClC1=CC=C2NC(=O)C(=O)C2=C1 GTRAJYAKFCHEKL-UHFFFAOYSA-N 0.000 description 1
- VOWWYDCFAISREI-UHFFFAOYSA-N Bisphenol AP Chemical compound C=1C=C(O)C=CC=1C(C=1C=CC(O)=CC=1)(C)C1=CC=CC=C1 VOWWYDCFAISREI-UHFFFAOYSA-N 0.000 description 1
- HTVITOHKHWFJKO-UHFFFAOYSA-N Bisphenol B Chemical compound C=1C=C(O)C=CC=1C(C)(CC)C1=CC=C(O)C=C1 HTVITOHKHWFJKO-UHFFFAOYSA-N 0.000 description 1
- SDDLEVPIDBLVHC-UHFFFAOYSA-N Bisphenol Z Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCCC1 SDDLEVPIDBLVHC-UHFFFAOYSA-N 0.000 description 1
- NPVMJQQOZGYOOL-UHFFFAOYSA-N C(C1=CC=CC=C1)OCCOC1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)OCCOCC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)OCCOC1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)OCCOCC2=CC=CC=C2 NPVMJQQOZGYOOL-UHFFFAOYSA-N 0.000 description 1
- LHZCZKCNFZYPRZ-UHFFFAOYSA-N C(CCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCC Chemical compound C(CCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCC LHZCZKCNFZYPRZ-UHFFFAOYSA-N 0.000 description 1
- NGTITOAITFWCHM-UHFFFAOYSA-N C(CCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCC Chemical compound C(CCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCC NGTITOAITFWCHM-UHFFFAOYSA-N 0.000 description 1
- HXAWDAYPZUSQEJ-UHFFFAOYSA-N C(CCCCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCCCC Chemical compound C(CCCCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCCCC HXAWDAYPZUSQEJ-UHFFFAOYSA-N 0.000 description 1
- MPNIDICTVWBYQQ-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCCCCCCCCCC Chemical compound C(CCCCCCCCCCCCCCCCC)C1=CC=C(C=C1)C1OCC2(CO1)COC(OC2)C2=CC=C(C=C2)CCCCCCCCCCCCCCCCCC MPNIDICTVWBYQQ-UHFFFAOYSA-N 0.000 description 1
- HPYFKAKXLHPEMH-UHFFFAOYSA-N C1C2(COC(O1)C3=CC=C(C=C3)OCC4=CC=CC=C4)COC(OC2)C5=CC=C(C=C5)OCC6=CC=CC=C6 Chemical compound C1C2(COC(O1)C3=CC=C(C=C3)OCC4=CC=CC=C4)COC(OC2)C5=CC=C(C=C5)OCC6=CC=CC=C6 HPYFKAKXLHPEMH-UHFFFAOYSA-N 0.000 description 1
- RIZMTTFEMUJJNB-UHFFFAOYSA-N CC(=O)C1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)C(=O)C Chemical compound CC(=O)C1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)C(=O)C RIZMTTFEMUJJNB-UHFFFAOYSA-N 0.000 description 1
- KAIOBKMPUVNSTA-UHFFFAOYSA-N CC(C)(C)C1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)C(C)(C)C Chemical compound CC(C)(C)C1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)C(C)(C)C KAIOBKMPUVNSTA-UHFFFAOYSA-N 0.000 description 1
- DDRGYWBHFNZQJC-UHFFFAOYSA-N CC1=C(C(=CC=C1)C)C2OCC3(CO2)COC(OC3)C4=C(C=CC=C4C)C Chemical compound CC1=C(C(=CC=C1)C)C2OCC3(CO2)COC(OC3)C4=C(C=CC=C4C)C DDRGYWBHFNZQJC-UHFFFAOYSA-N 0.000 description 1
- XPYDINYSVOPIRE-UHFFFAOYSA-N CC1=CC(=CC(=C1)C2OCC3(CO2)COC(OC3)C4=CC(=CC(=C4)C)C)C Chemical compound CC1=CC(=CC(=C1)C2OCC3(CO2)COC(OC3)C4=CC(=CC(=C4)C)C)C XPYDINYSVOPIRE-UHFFFAOYSA-N 0.000 description 1
- UAGIFJSZUNTLHA-UHFFFAOYSA-N CC1=CC=C(C=C1)C2OCC3(COC(OC3)C4=CC=CC=C4)CO2 Chemical compound CC1=CC=C(C=C1)C2OCC3(COC(OC3)C4=CC=CC=C4)CO2 UAGIFJSZUNTLHA-UHFFFAOYSA-N 0.000 description 1
- PTHADPYNVOMRPQ-UHFFFAOYSA-N CC1=CC=CC=C1C2OCC3(CO2)COC(OC3)C4=CC=CC=C4C Chemical compound CC1=CC=CC=C1C2OCC3(CO2)COC(OC3)C4=CC=CC=C4C PTHADPYNVOMRPQ-UHFFFAOYSA-N 0.000 description 1
- BZAPBPARIPBZEC-UHFFFAOYSA-N CCCCC1=CC=C(C=C1)C2OCC3(COC(OC3)C4=CC=C(C=C4)CC)CO2 Chemical compound CCCCC1=CC=C(C=C1)C2OCC3(COC(OC3)C4=CC=C(C=C4)CC)CO2 BZAPBPARIPBZEC-UHFFFAOYSA-N 0.000 description 1
- HBWINDSNDWZSMB-UHFFFAOYSA-N CCCCCCCCCC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)CCCCCCCCC Chemical compound CCCCCCCCCC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)CCCCCCCCC HBWINDSNDWZSMB-UHFFFAOYSA-N 0.000 description 1
- AMASWWQZTYTZNG-UHFFFAOYSA-N CCOCCOC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)OCCOCC Chemical compound CCOCCOC1=CC=C(C=C1)C2OCC3(CO2)COC(OC3)C4=CC=C(C=C4)OCCOCC AMASWWQZTYTZNG-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004419 Panlite Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KYPYTERUKNKOLP-UHFFFAOYSA-N Tetrachlorobisphenol A Chemical compound C=1C(Cl)=C(O)C(Cl)=CC=1C(C)(C)C1=CC(Cl)=C(O)C(Cl)=C1 KYPYTERUKNKOLP-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920003232 aliphatic polyester Chemical group 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001341 alkaline earth metal compounds Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229940058905 antimony compound for treatment of leishmaniasis and trypanosomiasis Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical class ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- LUFPJJNWMYZRQE-UHFFFAOYSA-N benzylsulfanylmethylbenzene Chemical compound C=1C=CC=CC=1CSCC1=CC=CC=C1 LUFPJJNWMYZRQE-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical group C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 1
- MUCRFDZUHPMASM-UHFFFAOYSA-N bis(2-chlorophenyl) carbonate Chemical compound ClC1=CC=CC=C1OC(=O)OC1=CC=CC=C1Cl MUCRFDZUHPMASM-UHFFFAOYSA-N 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- VEIOBOXBGYWJIT-UHFFFAOYSA-N cyclohexane;methanol Chemical compound OC.OC.C1CCCCC1 VEIOBOXBGYWJIT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical class C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- QLVWOKQMDLQXNN-UHFFFAOYSA-N dibutyl carbonate Chemical compound CCCCOC(=O)OCCCC QLVWOKQMDLQXNN-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 150000002291 germanium compounds Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002366 halogen compounds Chemical group 0.000 description 1
- 239000012760 heat stabilizer Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000002908 osmium compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- SJDACOMXKWHBOW-UHFFFAOYSA-N oxyphenisatine Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2NC1=O SJDACOMXKWHBOW-UHFFFAOYSA-N 0.000 description 1
- QBDSZLJBMIMQRS-UHFFFAOYSA-N p-Cumylphenol Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=CC=C1 QBDSZLJBMIMQRS-UHFFFAOYSA-N 0.000 description 1
- NKTOLZVEWDHZMU-UHFFFAOYSA-N p-cumyl phenol Natural products CC1=CC=C(C)C(O)=C1 NKTOLZVEWDHZMU-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000004023 quaternary phosphonium compounds Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- RKHXQBLJXBGEKF-UHFFFAOYSA-M tetrabutylphosphanium;bromide Chemical compound [Br-].CCCC[P+](CCCC)(CCCC)CCCC RKHXQBLJXBGEKF-UHFFFAOYSA-M 0.000 description 1
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 description 1
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000001721 transfer moulding Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 150000003755 zirconium compounds Chemical class 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ポリカーボネート
樹脂およびベンザル構造をもつ特定のアセタール化合物
からなるポリカーボネート樹脂組成物及び医療用器具の
部材用のポリカーボネート樹脂組成物に関する。更に詳
しくは、医療用器具の滅菌処理に用いられる電離放射線
に対して安定化させたポリカーボネート樹脂組成物及び
医療用器具の部材用のポリカーボネート樹脂組成物に関
する。The present invention relates to a polycarbonate resin composition comprising a polycarbonate resin and a specific acetal compound having a benzal structure, and a polycarbonate resin composition for a member of a medical device. More specifically, the present invention relates to a polycarbonate resin composition stabilized against ionizing radiation used for sterilization treatment of a medical instrument and a polycarbonate resin composition for a member of a medical instrument.
【0002】[0002]
【従来の技術】ポリカ−ボネ−ト樹脂は、機械的強度、
透明性、耐熱性、耐衝撃性の優れた熱可塑性樹脂として
広範な用途に使用されている。該樹脂は、かかる優れた
特性により、特に注射器、外科用具、手術用器具等を収
容、包装する容器、人工肺、人工腎臓、麻酔吸収装置、
静脈用コネクタ−及び付属品、血液分離装置等の医療用
装置、外科用具、手術用具など、各種の医療用器具の部
材として使用されている。2. Description of the Related Art Polycarbonate resin has mechanical strength,
It is widely used as a thermoplastic resin with excellent transparency, heat resistance and impact resistance. Due to such excellent properties, the resin is particularly suitable for containing and packaging syringes, surgical tools, surgical instruments, etc., artificial lungs, artificial kidneys, anesthesia absorbing devices,
It is used as a member of various medical instruments such as intravenous connectors and accessories, medical devices such as blood separation devices, surgical tools, and surgical tools.
【0003】これらの医療用途では、通常、完全な滅菌
処理が施される。該滅菌処理には、エチレンオキシドガ
ス接触処理、オ−トクレ−ブ中での高圧水蒸気による高
温湿熱処理、γ線、電子線等の電離放射線の照射処理が
挙げられる。これらの中で、エチレンオキシド法は、ガ
ス自体の安全性、毒性(特に発ガン性等)の問題、被処
理医療用器具における残留ガスの問題、廃棄処理に関連
する環境問題などがあり好ましくない。水蒸気滅菌法
は、高温湿熱処理のため材料の変形、加水分解による劣
化、処理コストが高いなどの問題点があるほか、滅菌処
理後に乾燥工程がさらに必要である。一方、電離放射線
処理法は、製品への残留問題がなく、低温下乾燥状態で
処理でき、処理コストが比較的低い等の利点があり、ま
た該放射線はその物質透過性により包装済の製品での滅
菌処理が実施できるため、盛んに用いられてきている。[0003] In these medical applications, complete sterilization is usually performed. Examples of the sterilization treatment include an ethylene oxide gas contact treatment, a high-temperature and wet heat treatment using high-pressure steam in an autoclave, and a treatment of ionizing radiation such as γ-ray and electron beam. Among them, the ethylene oxide method is not preferred because it has problems of safety of the gas itself, toxicity (especially carcinogenicity, etc.), problems of residual gas in the medical device to be treated, and environmental problems related to disposal. The steam sterilization method has problems such as deformation of the material due to high temperature and humidity heat treatment, deterioration due to hydrolysis, and high processing cost, and further requires a drying step after the sterilization treatment. On the other hand, the ionizing radiation treatment method has the advantages that there is no problem of remaining in the product, the treatment can be performed in a dry state at a low temperature, the treatment cost is relatively low, and the like. Since it can be sterilized, it has been widely used.
【0004】しかしながら、ポリカ−ボネ−ト樹脂はか
かる電離放射線の照射を受けると、化学変化を伴い黄色
に変色する。この変色は、医療用途では内容物の正確な
色調が見られなくなるなど商品的価値を著しく損なう。However, when the polycarbonate resin is irradiated with such ionizing radiation, the polycarbonate resin changes its color to yellow with a chemical change. This discoloration significantly impairs commercial value, such as the inability to see the correct color tone of the contents in medical applications.
【0005】かかる黄変を防止することを目的に種々の
試みがなされている。例えば樹脂中に青系着色剤を添加
して黄色味を相殺する方法が知られている。しかしなが
ら、かかる方法では、該着色剤の添加量により黄色味を
消すことはできるが、全体に暗色化し商品的価値をやは
り損ねてしまう。Various attempts have been made to prevent such yellowing. For example, there is known a method of adding a bluish colorant to a resin to cancel the yellow tint. However, in such a method, although the yellow tint can be eliminated by the amount of the coloring agent added, the color becomes darker as a whole, and the commercial value is also impaired.
【0006】また、ポリエ−テルポリオ−ル又はそのア
ルキルエ−テルを添加する方法が知られている(特開昭
62−135556号公報)。かかる方法では、ある程
度の改善はなされるが、未だ不十分であり、また、該化
合物の添加により成形加工時にポリカ−ボネ−ト樹脂の
分解及びヤケなどが発生しやすい問題があった。A method of adding a polyether polyol or an alkyl ether thereof is also known (Japanese Patent Application Laid-Open No. 62-135556). Such a method provides some improvement but is still insufficient, and there is a problem that the addition of the compound easily causes decomposition of the polycarbonate resin and burns during molding.
【0007】さらに、芳香族ハロゲン化合物を添加する
方法が開示されている(特開平2−129261号公
報)。この方法は、ポリカ−ボネ−ト樹脂に対しかなり
良好な安定化効果を与えるが、ハロゲン化合物であり、
安全性及び廃棄処理に関連する環境問題を避けることが
できないという問題がある。Further, a method of adding an aromatic halogen compound has been disclosed (JP-A-2-129261). This method gives a rather good stabilizing effect on the polycarbonate resin, but it is a halogen compound,
There is the problem that environmental issues related to safety and disposal cannot be avoided.
【0008】[0008]
【発明が解決しようとする課題】本発明の目的は、物性
劣化が少なく電離放射線滅菌の際の黄変が非常に小さい
ポリカーボネート樹脂組成物及び医療用器具の部材用の
ポリカーボネート樹脂組成物を提供することにある。本
発明者は、かかる目的を達成せんとして鋭意研究した結
果、ベンザル構造をもつ特定のアセタール化合物をポリ
カ−ボネ−ト樹脂に配合することにより、電離放射線滅
菌の際の黄変が非常に小さくなることを見出し、本発明
に到達した。SUMMARY OF THE INVENTION An object of the present invention is to provide a polycarbonate resin composition which causes little deterioration in physical properties and has a very small yellowing upon ionizing radiation sterilization, and a polycarbonate resin composition for a member of a medical instrument. It is in. The present inventor has conducted intensive studies to achieve the object, and as a result, by adding a specific acetal compound having a benzal structure to a polycarbonate resin, yellowing upon ionizing radiation sterilization becomes extremely small. The inventors have found that the present invention has been achieved.
【0009】[0009]
【課題を解決するための手段】すなわち、本発明によれ
ば、ポリカーボネート樹脂100重量部および下記式
(1)で示されるアセタール化合物0.001〜20重
量部からなる電離放射線安定化ポリカーボネート樹脂組
成物が提供される。According to the present invention, an ionizing radiation-stabilized polycarbonate resin composition comprising 100 parts by weight of a polycarbonate resin and 0.001 to 20 parts by weight of an acetal compound represented by the following formula (1): Is provided.
【0010】[0010]
【化2】 Embedded image
【0011】(式中、mおよびnは0〜5の整数であ
り、R1およびR2は、それぞれ同一でも異なっていても
よく、炭素数1〜18の炭化水素基、炭素数1〜18の
炭化水素オキシ基、炭素数1〜18のアシル基、炭素数
1〜18のアシロキシ基および炭素数2〜8のポリオキ
シ炭化水素基からなる群より選ばれる少なくとも1つの
基を示す。)(Wherein m and n are integers from 0 to 5; R 1 and R 2 may be the same or different; each represents a hydrocarbon group having 1 to 18 carbon atoms; At least one group selected from the group consisting of a hydrocarbon oxy group, an acyl group having 1 to 18 carbon atoms, an acyloxy group having 1 to 18 carbon atoms, and a polyoxyhydrocarbon group having 2 to 8 carbon atoms.)
【0012】本発明で使用されるポリカ−ボネ−ト樹脂
とは、種々の芳香族ジヒドロキシ化合物又はこれと少量
のポリヒドロキシ化合物をホスゲンと反応させる界面縮
重合法又はジフェニルカ−ボネ−ト等の炭酸エステルと
反応させる溶融重合法によって合成される分岐していて
もよい熱可塑性芳香族ポリカ−ボネ−トの重合体又は共
重合体である。その代表例としては、2,2−ビス(4
−ヒドロキシフェニル)プロパン(ビスフェノールA)
から合成されるポリカ−ボネ−トが挙げられる。The polycarbonate resin used in the present invention includes various aromatic dihydroxy compounds or an interfacial polycondensation method in which a small amount of the polyhydroxy compound is reacted with phosgene, or a diphenyl carbonate or the like. It is a polymer or copolymer of an optionally branched thermoplastic aromatic polycarbonate synthesized by a melt polymerization method of reacting with a carbonate ester. A typical example is 2,2-bis (4
-Hydroxyphenyl) propane (bisphenol A)
And polycarbonate synthesized from the following.
【0013】前記芳香族ジヒドロキシ化合物としては、
ビスフェノールA、ビス(4−ヒドロキシフェニル)メ
タン、1,1−ビス(4−ヒドロキシフェニル)エタ
ン、2,2−ビス(4−ヒドロキシフェニル)ブタン、
2,2−ビス(4−ヒドロキシフェニル)オクタン、ビ
ス(4−ヒドロキシフェニル)フェニルメタン、2,2
−ビス(4−ヒドロキシ−3−メチルフェニル)プロパ
ン、2,2−ビス(4−ヒドロキシ−3−tert−ブ
チルフェニル)プロパン、2,2−ビス(4−ヒドロキ
シ−3−ブロモフェニル)プロパン、2,2−ビス(4
−ヒドロキシ−3,5−ジブロモフェニル)プロパン、
2,2−ビス(4−ヒドロキシ−3,5−ジクロロフェ
ニル)プロパン、2,2−ビス(4−ヒドロキシ−3,
5−ジメチルフェニル)プロパン、2,2−ビス(3−
フェニル−4−ヒドロキシフェニル)プロパン、2,2
−ビス(3−シクロヘキシル−4−ヒドロキシフェニ
ル)プロパン、1,1−ビス(4−ヒドロキシフェニ
ル)−1−フェニルエタン、ビス(4−ヒドロキシフェ
ニル)ジフェニルメタン、9,9−ビス(4−ヒドロキ
シフェニル)フルオレン、9,9−ビス(4−ヒドロキ
シ−3−メチルフェニル)フルオレン、1,1−ビス
(4−ヒドロキシフェニル)シクロヘキサン、1,1−
ビス(4−ヒドロキシフェニル)−3,3,5−トリメ
チルシクロヘキサン、1,1−ビス(4−ヒドロキシフ
ェニル)シクロペンタン、4,4’−ジヒドロキシジフ
ェニルエ−テル、4,4’−ジヒドロキシ−3,3’−
ジメチルジフェニルエ−テル、4,4’−ジヒドロキシ
ジフェニルスルフィド、4,4’−ジヒドロキシジフェ
ニルスルホキシド、4,4’−ジヒドロキシジフェニル
スルホン、4,4’−ジヒドロキシ−3,3’−ジフェ
ニルスルフィド、4,4’−ジヒドロキシ−3,3’−
ジフェニルスルホキシド、4,4’−ジヒドロキシ−
3,3’−ジフェニルスルホン、1,3−ビス{2−
(4−ヒドロキシフェニル)プロピル}ベンゼン、1,
4−ビス{2−(4−ヒドロキシフェニル)プロピル}
ベンゼン、ハイドロキノン、レゾルシン、4,4’−ジ
ヒドロキシジフェニル等が挙げられ、ビスフェノールA
が好ましく用いられる。これらの化合物は1種類または
2種類以上混合して用いることができる。The aromatic dihydroxy compound includes:
Bisphenol A, bis (4-hydroxyphenyl) methane, 1,1-bis (4-hydroxyphenyl) ethane, 2,2-bis (4-hydroxyphenyl) butane,
2,2-bis (4-hydroxyphenyl) octane, bis (4-hydroxyphenyl) phenylmethane, 2,2
-Bis (4-hydroxy-3-methylphenyl) propane, 2,2-bis (4-hydroxy-3-tert-butylphenyl) propane, 2,2-bis (4-hydroxy-3-bromophenyl) propane, 2,2-bis (4
-Hydroxy-3,5-dibromophenyl) propane,
2,2-bis (4-hydroxy-3,5-dichlorophenyl) propane, 2,2-bis (4-hydroxy-3,
5-dimethylphenyl) propane, 2,2-bis (3-
Phenyl-4-hydroxyphenyl) propane, 2,2
-Bis (3-cyclohexyl-4-hydroxyphenyl) propane, 1,1-bis (4-hydroxyphenyl) -1-phenylethane, bis (4-hydroxyphenyl) diphenylmethane, 9,9-bis (4-hydroxyphenyl) ) Fluorene, 9,9-bis (4-hydroxy-3-methylphenyl) fluorene, 1,1-bis (4-hydroxyphenyl) cyclohexane, 1,1-
Bis (4-hydroxyphenyl) -3,3,5-trimethylcyclohexane, 1,1-bis (4-hydroxyphenyl) cyclopentane, 4,4′-dihydroxydiphenyl ether, 4,4′-dihydroxy-3 , 3'-
Dimethyldiphenyl ether, 4,4'-dihydroxydiphenyl sulfide, 4,4'-dihydroxydiphenyl sulfoxide, 4,4'-dihydroxydiphenyl sulfone, 4,4'-dihydroxy-3,3'-diphenyl sulfide, 4, 4'-dihydroxy-3,3'-
Diphenylsulfoxide, 4,4'-dihydroxy-
3,3'-diphenylsulfone, 1,3-bis {2-
(4-hydroxyphenyl) propyl @ benzene, 1,
4-bis {2- (4-hydroxyphenyl) propyl}
Benzene, hydroquinone, resorcinol, 4,4'-dihydroxydiphenyl and the like;
Is preferably used. These compounds can be used alone or in combination of two or more.
【0014】また、分岐した芳香族ポリカ−ボネ−ト樹
脂を得るには、フロログリシン、2,6−ジメチル−
2,4,6−トリス(4−ヒドロキシフェニル)−3−
ヘプテン、4,6−ジメチル−2,4,6−トリス(4
−ヒドロキシフェニル)−2−ヘプテン、1,3,5−
トリス(2−ヒドロキシフェニル)ベンゾ−ル、1,
1,1−トリス(4−ヒドロキシフェニル)エタン、
2,6−ビス(2−ヒドロキシ−5−メチルベンジル)
−4−メチルフェノ−ル、α,α’,α”−トリス(4
−ヒドロキシフェニル)−1,3,5−トリイソプロピ
ルベンゼン、3,3−ビス(4−ヒドロキシフェニル)
オキシインド−ル(イサチンビスフェノ−ル)、5−ク
ロロイサチンビスフェノ−ル、5−ブロモイサチンビス
フェノ−ル、5,7−ジクロロイサチンビスフェノ−ル
などを用いればよい。In order to obtain a branched aromatic polycarbonate resin, phloroglysin, 2,6-dimethyl-
2,4,6-tris (4-hydroxyphenyl) -3-
Heptene, 4,6-dimethyl-2,4,6-tris (4
-Hydroxyphenyl) -2-heptene, 1,3,5-
Tris (2-hydroxyphenyl) benzol, 1,
1,1-tris (4-hydroxyphenyl) ethane,
2,6-bis (2-hydroxy-5-methylbenzyl)
-4-methylphenol, α, α ′, α ″ -tris (4
-Hydroxyphenyl) -1,3,5-triisopropylbenzene, 3,3-bis (4-hydroxyphenyl)
Oxyindole (isatin bisphenol), 5-chloroisatin bisphenol, 5-bromoisatin bisphenol, 5,7-dichloroisatin bisphenol may be used.
【0015】界面重縮合法による反応は、通常二価フェ
ノールとホスゲンとの反応であり、酸結合剤および有機
溶媒の存在下に反応させる。酸結合剤としては、例えば
水酸化ナトリウム、水酸化カリウム等のアルカリ金属水
酸化物またはピリジン等のアミン化合物が用いられる。
有機溶媒としては、例えば塩化メチレン、クロルベンゼ
ン等のハロゲン化炭化水素が用いられる。また、反応促
進のために例えばトリエチルアミン、テトラ−n−ブチ
ルアンモニウムブロマイド、テトラ−n−ブチルホスホ
ニウムブロマイド等の第三級アミン、第四級アンモニウ
ム化合物、第四級ホスホニウム化合物等の触媒を用いる
こともできる。その際、反応温度は通常0〜40℃、反
応時間は10分〜5時間程度、反応中のpHは9以上に
保つのが好ましい。The reaction by the interfacial polycondensation method is usually a reaction between dihydric phenol and phosgene, and is carried out in the presence of an acid binder and an organic solvent. As the acid binder, for example, an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide or an amine compound such as pyridine is used.
As the organic solvent, for example, halogenated hydrocarbons such as methylene chloride and chlorobenzene are used. Further, for promoting the reaction, for example, a catalyst such as a tertiary amine such as triethylamine, tetra-n-butylammonium bromide, or tetra-n-butylphosphonium bromide, a quaternary ammonium compound, or a quaternary phosphonium compound may be used. it can. At that time, the reaction temperature is usually 0 to 40 ° C., the reaction time is preferably about 10 minutes to 5 hours, and the pH during the reaction is preferably maintained at 9 or more.
【0016】また、かかる重合反応において、通常末端
停止剤が使用される。かかる末端停止剤として単官能フ
ェノール類を使用することができる。単官能フェノール
類は末端停止剤として分子量調節のために一般的に使用
され、また得られたポリカーボネート樹脂は、末端が単
官能フェノール類に基づく基によって封鎖されているの
で、そうでないものと比べて熱安定性に優れている。か
かる単官能フェノール類の具体例としては、例えばフェ
ノール、p−tert−ブチルフェノール、p−クミル
フェノールおよびイソオクチルフェノールが挙げられ
る。また、他の単官能フェノール類としては、長鎖のア
ルキル基あるいは脂肪族ポリエステル基を置換基として
有するフェノール類または安息香酸クロライド類、もし
くは長鎖のアルキルカルボン酸クロライド類を使用する
ことができる。In such a polymerization reaction, a terminal stopper is usually used. Monofunctional phenols can be used as such a terminal stopper. Monofunctional phenols are commonly used as molecular terminators for molecular weight control, and the resulting polycarbonate resins are capped by groups based on monofunctional phenols, so that Excellent heat stability. Specific examples of such monofunctional phenols include, for example, phenol, p-tert-butylphenol, p-cumylphenol and isooctylphenol. Further, as other monofunctional phenols, phenols or benzoic acid chlorides having a long-chain alkyl group or aliphatic polyester group as a substituent, or long-chain alkyl carboxylic acid chlorides can be used.
【0017】これらの末端停止剤は、得られたポリカー
ボネート樹脂の全末端に対して少くとも5モル%、好ま
しくは少くとも10モル%末端に導入されることが望ま
しく、また、末端停止剤は単独でまたは2種以上混合し
て使用してもよい。It is desirable that these terminal stoppers are introduced at least at 5 mol%, preferably at least 10 mol%, based on all terminals of the obtained polycarbonate resin. Or a mixture of two or more.
【0018】溶融重合法による反応は、通常二価フェノ
ールとカーボネートエステルとのエステル交換反応であ
り、不活性ガスの存在下に二価フェノールとカーボネー
トエステルとを加熱しながら混合して、生成するアルコ
ールまたはフェノールを留出させる方法により行われ
る。反応温度は生成するアルコールまたはフェノールの
沸点等により異なるが、通常120〜350℃の範囲で
ある。反応後期には系を10〜0.1Torr程度に減
圧して生成するアルコールまたはフェノールの留出を容
易にさせる。反応時間は通常1〜4時間程度である。The reaction by the melt polymerization method is usually a transesterification reaction between a dihydric phenol and a carbonate ester. The dihydric phenol and the carbonate ester are mixed while heating in the presence of an inert gas to form an alcohol. Alternatively, it is carried out by a method of distilling phenol. The reaction temperature varies depending on the boiling point of the produced alcohol or phenol, but is usually in the range of 120 to 350 ° C. In the latter half of the reaction, the pressure of the system is reduced to about 10 to 0.1 Torr to facilitate the distillation of the alcohol or phenol produced. The reaction time is usually about 1 to 4 hours.
【0019】カーボネートエステルとしては、置換され
ていてもよい炭素数6〜15のアリール基、アラルキル
基あるいは炭素数1〜4のアルキル基などのエステルが
挙げられる。具体的にはジフェニルカーボネート、ビス
(クロロフェニル)カーボネート、m―クレジルカーボ
ネート、ジナフチルカーボネート、ビス(ジフェニル)
カーボネート、ジメチルカーボネート、ジエチルカーボ
ネート、ジブチルカーボネートなどが挙げられ、なかで
もジフェニルカーボネートが好ましい。Examples of the carbonate ester include an optionally substituted ester such as an aryl group having 6 to 15 carbon atoms, an aralkyl group or an alkyl group having 1 to 4 carbon atoms. Specifically, diphenyl carbonate, bis (chlorophenyl) carbonate, m-cresyl carbonate, dinaphthyl carbonate, bis (diphenyl)
Examples thereof include carbonate, dimethyl carbonate, diethyl carbonate, and dibutyl carbonate. Among them, diphenyl carbonate is preferable.
【0020】また、重合速度を速めるために重合触媒を
用いることができ、かかる重合触媒としては、例えば水
酸化ナトリウム、水酸化カリウム、二価フェノールのナ
トリウム塩、カリウム塩等のアルカリ金属化合物、水酸
化カルシウム、水酸化バリウム、水酸化マグネシウム等
のアルカリ土類金属化合物、テトラメチルアンモニウム
ヒドロキシド、テトラエチルアンモニウムヒドロキシ
ド、トリメチルアミン、トリエチルアミン等の含窒素塩
基性化合物、アルカリ金属やアルカリ土類金属のアルコ
キシド類、アルカリ金属やアルカリ土類金属の有機酸塩
類、亜鉛化合物類、ホウ素化合物類、アルミニウム化合
物類、珪素化合物類、ゲルマニウム化合物類、有機スズ
化合物類、鉛化合物類、オスミウム化合物類、アンチモ
ン化合物類マンガン化合物類、チタン化合物類、ジルコ
ニウム化合物類などの通常エステル化反応、エステル交
換反応に使用される触媒を用いることができる。触媒は
単独で使用してもよいし、2種以上組み合わせて使用し
てもよい。これらの重合触媒の使用量は、原料の二価フ
ェノール1モルに対し、好ましくは1×10-9〜1×1
0-3当量、より好ましくは1×10-8〜5×10-4当量
の範囲で選ばれる。A polymerization catalyst can be used to increase the polymerization rate. Examples of the polymerization catalyst include sodium hydroxide, potassium hydroxide, alkali metal compounds such as sodium and potassium salts of dihydric phenol, and water. Alkaline earth metal compounds such as calcium oxide, barium hydroxide and magnesium hydroxide; nitrogen-containing basic compounds such as tetramethylammonium hydroxide, tetraethylammonium hydroxide, trimethylamine and triethylamine; alkoxides of alkali metals and alkaline earth metals Manganese, organic acid salts of alkali metals and alkaline earth metals, zinc compounds, boron compounds, aluminum compounds, silicon compounds, germanium compounds, organic tin compounds, lead compounds, osmium compounds, antimony compounds Compounds, titanium compounds, usually the esterification reaction, such as zirconium compounds, there can be used a catalyst used in the transesterification reaction. The catalyst may be used alone or in combination of two or more. The amount of the polymerization catalyst used is preferably 1 × 10 −9 to 1 × 1 with respect to 1 mol of the dihydric phenol as the raw material.
It is selected in the range of 0 -3 equivalents, more preferably 1 × 10 -8 to 5 × 10 -4 equivalents.
【0021】ポリカーボネート樹脂の分子量は、粘度平
均分子量(M)で10,000〜100,000が好まし
く、11,000〜45,000がより好ましく、12,
000〜30,000が特に好ましい。かかる粘度平均
分子量を有するポリカーボネート樹脂は、十分な強度が
得られ、また、成形時の溶融流動性も良好であり成形歪
みが発生せず好ましい。かかる粘度平均分子量は塩化メ
チレン100mlにポリカーボネート樹脂0.7gを2
0℃で溶解した溶液から求めた比粘度(ηsp)を次式に
挿入して求めたものである。 ηsp/c=[η]+0.45×[η]2c(但し[η]
は極限粘度) [η]=1.23×10-4M0.83 c=0.7The polycarbonate resin has a viscosity average molecular weight (M) of preferably 10,000 to 100,000, more preferably 11,000 to 45,000, and
000 to 30,000 are particularly preferred. A polycarbonate resin having such a viscosity average molecular weight is preferable because sufficient strength is obtained, the melt fluidity during molding is good, and molding distortion does not occur. The viscosity average molecular weight of 0.7 g of polycarbonate resin in 100 ml of methylene chloride is 2
The specific viscosity (η sp ) obtained from the solution dissolved at 0 ° C. was obtained by inserting it into the following equation. η sp /c=[η]+0.45×[η] 2 c (where [η]
Is the intrinsic viscosity) [η] = 1.23 × 10 −4 M 0.83 c = 0.7
【0022】本発明で使用されるアセタール化合物と
は、前記式(1)で示されるアセタール化合物であり、
前記式(1)中、mおよびnは0〜5の整数であり、好
ましくは0〜2の整数であり、R1およびR2は、それぞ
れ同一でも異なっていてもよく、炭素数1〜18の炭化
水素基、炭素数1〜18の炭化水素オキシ基、炭素数1
〜18のアシル基、炭素数1〜18のアシロキシ基およ
び炭素数2〜8のポリオキシ炭化水素基からなる群より
選ばれる少なくとも1つの基を示す。The acetal compound used in the present invention is an acetal compound represented by the above formula (1),
In the formula (1), m and n are an integer of 0 to 5, preferably an integer of 0 to 2, R 1 and R 2 may be the same or different, and have 1 to 18 carbon atoms. Hydrocarbon group, C1-C18 hydrocarbonoxy group, C1
And at least one group selected from the group consisting of an acyl group having 1 to 18 carbon atoms, an acyloxy group having 1 to 18 carbon atoms and a polyoxyhydrocarbon group having 2 to 8 carbon atoms.
【0023】炭素数1〜18の炭化水素基としては、炭
素数1〜18、好ましくは炭素数1〜15のアルキル
基、アラルキル基またはアリール基であり、具体的に
は、メチル、エチル、ブチル、iso−ブチル、ter
t−ブチル、オクチル、ノニル、デシル、オクタデシ
ル、ベンジル、フェニルなどが挙げられる。The hydrocarbon group having 1 to 18 carbon atoms is an alkyl group, aralkyl group or aryl group having 1 to 18 carbon atoms, preferably 1 to 15 carbon atoms, and specifically, methyl, ethyl, butyl , Iso-butyl, ter
t-butyl, octyl, nonyl, decyl, octadecyl, benzyl, phenyl and the like.
【0024】炭素数1〜18の炭化水素オキシ基として
は、炭素数1〜18、好ましくは炭素数1〜15のアル
キルオキシ基、アラルキルオキシ基またはアリールオキ
シ基であり、具体的には、メトキシ、ブトキシ、オクチ
ルオキシ、ステアリルオキシ、ラウリルオキシ、フェノ
キシ、ベンジルオキシなどが挙げられる。The hydrocarbon oxy group having 1 to 18 carbon atoms is an alkyloxy group, an aralkyloxy group or an aryloxy group having 1 to 18 carbon atoms, preferably 1 to 15 carbon atoms. , Butoxy, octyloxy, stearyloxy, lauryloxy, phenoxy, benzyloxy and the like.
【0025】炭素数1〜18のアシル基としては、具体
的には、アセチル、プロピオニル、ブチリル、ステアロ
イル、ラウロイル、ベンゾイルなどが挙げられる。Specific examples of the acyl group having 1 to 18 carbon atoms include acetyl, propionyl, butyryl, stearoyl, lauroyl, benzoyl and the like.
【0026】炭素数1〜18のアシロキシ基としては、
具体的には、アセトキシ、プロピオニルオキシ、ブチリ
ルオキシ、ステアロイルオキシ、ベンゾイルオキシなど
が挙げられる。The acyloxy group having 1 to 18 carbon atoms includes
Specific examples include acetoxy, propionyloxy, butyryloxy, stearoyloxy, benzoyloxy and the like.
【0027】炭素数2〜8のポリオキシ炭化水素基とし
ては、具体的には、エトキシエトキシ、ベンジルオキシ
エトキシなどが挙げられる。Specific examples of the C 2-8 polyoxyhydrocarbon group include ethoxyethoxy and benzyloxyethoxy.
【0028】前記式(1)で示されるアセタール化合物
として、具体的には、3,9−ジフェニル−2,4,
8,10−テトラオキサスピロ[5,5]ウンデカン、
3−(4−メチルフェニル)−9−フェニル−2,4,
8,10−テトラオキサスピロ[5,5]ウンデカン、
3,9−ビス(2−メチルフェニル)−2,4,8,1
0−テトラオキサスピロ[5,5]ウンデカン、3,9
−ビス(3−メチルフェニル)−2,4,8,10−テ
トラオキサスピロ[5,5]ウンデカン、3,9−ビス
(4−メチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、3,9−ビス(2,
4−ジメチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、3,9−ビス(2,
5−ジメチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、3,9−ビス(2,
6−ジメチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、3,9−ビス(3,
5−ジメチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、As the acetal compound represented by the above formula (1), specifically, 3,9-diphenyl-2,4,4
8,10-tetraoxaspiro [5,5] undecane,
3- (4-methylphenyl) -9-phenyl-2,4,
8,10-tetraoxaspiro [5,5] undecane,
3,9-bis (2-methylphenyl) -2,4,8,1
0-tetraoxaspiro [5,5] undecane, 3,9
-Bis (3-methylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-methylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2,
4-dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2,
5-dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2,
6-dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (3,
5-dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane,
【0029】3,9−ビス(4−iso−ブチルフェニ
ル)−2,4,8,10−テトラオキサスピロ[5,
5]ウンデカン、3−(4−エチルフェニル)−9−
(4−ブチルフェニル)−2,4,8,10−テトラオ
キサスピロ[5,5]ウンデカン、3,9−ビス(4−
tert−ブチルフェニル)−2,4,8,10−テト
ラオキサスピロ[5,5]ウンデカン、3,9−ビス
(4−オクチルフェニル)−2,4,8,10−テトラ
オキサスピロ[5,5]ウンデカン、3,9−ビス(4
−ノニルフェニル)−2,4,8,10−テトラオキサ
スピロ[5,5]ウンデカン、3,9−ビス(4−デシ
ルフェニル)−2,4,8,10−テトラオキサスピロ
[5,5]ウンデカン、3,9−ビス(4−ドデシルフ
ェニル)−2,4,8,10−テトラオキサスピロ
[5,5]ウンデカン、3,9−ビス(4−オクタデシ
ルフェニル)−2,4,8,10−テトラオキサスピロ
[5,5]ウンデカン、3,9−ビス(4−フェニルフ
ェニル)−2,4,8,10−テトラオキサスピロ
[5,5]ウンデカン、3,9-bis (4-iso-butylphenyl) -2,4,8,10-tetraoxaspiro [5
5] Undecane, 3- (4-ethylphenyl) -9-
(4-butylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-
tert-butylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-octylphenyl) -2,4,8,10-tetraoxaspiro [5, 5] undecane, 3,9-bis (4
-Nonylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-decylphenyl) -2,4,8,10-tetraoxaspiro [5,5 ] Undecane, 3,9-bis (4-dodecylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-octadecylphenyl) -2,4,8 , 10-Tetraoxaspiro [5,5] undecane, 3,9-bis (4-phenylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane,
【0030】3,9−ビス(4−メトキシフェニル)−
2,4,8,10−テトラオキサスピロ[5,5]ウン
デカン、3,9−ビス(4−ブトキシフェニル)−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン、3,9−ビス(4−ベンジルオキシフェニル)−
2,4,8,10−テトラオキサスピロ[5,5]ウン
デカン、3,9−ビス(4−アセチルフェニル)−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン、3,9−ビス{4−(エトキシエトキシ)フェニ
ル}−2,4,8,10−テトラオキサスピロ[5,
5]ウンデカン、3,9−ビス{4−(ベンジルオキシ
エトキシ)フェニル}−2,4,8,10−テトラオキ
サスピロ[5,5]ウンデカンなどが挙げられる。3,9-bis (4-methoxyphenyl)-
2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-butoxyphenyl) -2,
4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-benzyloxyphenyl)-
2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-acetylphenyl) -2,
4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis {4- (ethoxyethoxy) phenyl} -2,4,8,10-tetraoxaspiro [5,
5] undecane and 3,9-bis {4- (benzyloxyethoxy) phenyl} -2,4,8,10-tetraoxaspiro [5,5] undecane.
【0031】これらの中で、3,9−ジフェニル−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン、3,9−ビス(2−メチルフェニル)−2,4,
8,10−テトラオキサスピロ[5,5]ウンデカン、
3,9−ビス(3−メチルフェニル)−2,4,8,1
0−テトラオキサスピロ[5,5]ウンデカン、3,9
−ビス(4−メチルフェニル)−2,4,8,10−テ
トラオキサスピロ[5,5]ウンデカン、3,9−ビス
(2,4−ジメチルフェニル)−2,4,8,10−テ
トラオキサスピロ[5,5]ウンデカン、3,9−ビス
(2,5−ジメチルフェニル)−2,4,8,10−テ
トラオキサスピロ[5,5]ウンデカン、3,9−ビス
(4−iso−ブチルフェニル)−2,4,8,10−
テトラオキサスピロ[5,5]ウンデカンおよび3,9
−ビス(4−フェニルフェニル)−2,4,8,10−
テトラオキサスピロ[5,5]ウンデカンが好ましく、
特に、3,9−ジフェニル−2,4,8,10−テトラ
オキサスピロ[5,5]ウンデカン、3,9−ビス(3
−メチルフェニル)−2,4,8,10−テトラオキサ
スピロ[5,5]ウンデカン、3,9−ビス(2,4−
ジメチルフェニル)−2,4,8,10−テトラオキサ
スピロ[5,5]ウンデカン、3,9−ビス(4−is
o−ブチルフェニル)−2,4,8,10−テトラオキ
サスピロ[5,5]ウンデカンおよび3,9−ビス(4
−フェニルフェニル)−2,4,8,10−テトラオキ
サスピロ[5,5]ウンデカンが好ましい。これらのア
セタール化合物は単独でまたは2種類以上を混合して使
用することができる。Among these, 3,9-diphenyl-2,2
4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2-methylphenyl) -2,4
8,10-tetraoxaspiro [5,5] undecane,
3,9-bis (3-methylphenyl) -2,4,8,1
0-tetraoxaspiro [5,5] undecane, 3,9
-Bis (4-methylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2,4-dimethylphenyl) -2,4,8,10-tetra Oxaspiro [5,5] undecane, 3,9-bis (2,5-dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-iso -Butylphenyl) -2,4,8,10-
Tetraoxaspiro [5,5] undecane and 3,9
-Bis (4-phenylphenyl) -2,4,8,10-
Tetraoxaspiro [5,5] undecane is preferred,
In particular, 3,9-diphenyl-2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (3
-Methylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (2,4-
Dimethylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane, 3,9-bis (4-is
o-butylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane and 3,9-bis (4
-Phenylphenyl) -2,4,8,10-tetraoxaspiro [5,5] undecane is preferred. These acetal compounds can be used alone or in combination of two or more.
【0032】前記式(1)のアセタール化合物は、通常
ペンタエリスリトールと相当するベンズアルデヒド誘導
体とを、必要ならば該反応に関与しない有機溶媒で希釈
して、酸触媒の存在下での縮合反応で、通常は0℃から
120℃の温度条件下、30分間から15時間反応させ
て得ることができる。酸触媒としては、トルエンスルホ
ン酸、ベンゼンスルホン酸、メチルスルホン酸などの有
機酸、硫酸、塩酸、硝酸などの無機酸が挙げられる。有
機溶媒としては、ベンゼン、トルエン、シクロヘキサン
などの炭化水素化合物、ジオキサン、1,2−ジメトキ
シエタンなどのエーテル化合物、クロロベンゼン、1,
2−ジクロロエタンなどのハロゲン化炭化水素化合物な
どが挙げられる。本発明のアセタール化合物は、上記縮
合反応後の反応混合物から一般的な分離手段により得ら
れる。例えば、反応混合物からの濾取、または反応混合
物に水を添加し酸触媒を除いた後の有機層からの晶析、
溶媒留去などにより得ることができる。The acetal compound of the above formula (1) is prepared by diluting pentaerythritol and a corresponding benzaldehyde derivative with an organic solvent not involved in the reaction, if necessary, and subjecting the acetal compound to a condensation reaction in the presence of an acid catalyst. Usually, it can be obtained by reacting at a temperature of 0 ° C. to 120 ° C. for 30 minutes to 15 hours. Examples of the acid catalyst include organic acids such as toluenesulfonic acid, benzenesulfonic acid, and methylsulfonic acid, and inorganic acids such as sulfuric acid, hydrochloric acid, and nitric acid. Examples of the organic solvent include hydrocarbon compounds such as benzene, toluene, and cyclohexane; dioxane; ether compounds such as 1,2-dimethoxyethane; chlorobenzene;
Halogenated hydrocarbon compounds such as 2-dichloroethane are exemplified. The acetal compound of the present invention can be obtained from the reaction mixture after the above condensation reaction by general separation means. For example, filtration from the reaction mixture, or crystallization from the organic layer after adding water to the reaction mixture to remove the acid catalyst,
It can be obtained by evaporating the solvent.
【0033】本発明において、上記のアセタール化合物
は、ポリカ−ボネ−ト樹脂の電離放射線照射による変質
を抑制する効果があり、ポリカ−ボネ−ト樹脂の電離放
射線安定剤として使用することができる。In the present invention, the acetal compound has an effect of suppressing deterioration of the polycarbonate resin due to irradiation with ionizing radiation, and can be used as a stabilizer for ionizing radiation of the polycarbonate resin.
【0034】本発明において、ポリカ−ボネ−ト樹脂1
00重量部に対して、前記式(1)で示されるアセター
ル化合物は0.001〜20重量部の範囲であり、0.
01〜5重量部の範囲が好ましく、0.1〜3重量部の
範囲がより好ましい。0.001重量部より少ない場
合、耐電離放射線安定化効果が不十分であり、20重量
部より多い場合、ポリカ−ボネ−ト樹脂の物性を損ねた
り、コスト的に不利になることがあり好ましくない。In the present invention, the polycarbonate resin 1
The acetal compound represented by the formula (1) is in the range of 0.001 to 20 parts by weight with respect to 00 parts by weight.
The range is preferably from 01 to 5 parts by weight, more preferably from 0.1 to 3 parts by weight. When the amount is less than 0.001 part by weight, the effect of stabilizing ionizing radiation is insufficient, and when the amount is more than 20 parts by weight, the physical properties of the polycarbonate resin may be impaired or the cost may be disadvantageous. Absent.
【0035】また、前記アセタール化合物は、他の従来
公知の耐電離放射線安定剤と併用することができ、かか
る併用により相乗的に安定化効果が得られる場合があ
る。そのような化合物としては、例えば、ポリプロピレ
ングリコールのようなポリアルキレングリコ−ル、特開
平2−115260号公報に記載されたチオエーテル化
合物、特開平6−166807号公報に記載されたメル
カプト基を有する化合物、特開平8−225732号公
報、特開平8−225733号公報、特開平8−225
734号公報に記載されたベンジルエーテル、ベンジル
アルコールのようなベンジルオキシ構造を有するエーテ
ル、アルコール化合物やベンジルスルフィドのようなベ
ンジルチオ構造を有する硫黄化合物等が挙げられる。こ
れらの安定剤の使用量は、ポリカ−ボネ−ト樹脂100
重量部に対して、通常0.001〜15重量部の範囲で
用いられる。The acetal compound can be used in combination with other conventionally known stabilizers against ionizing radiation, and such a combination may provide a synergistic stabilizing effect. Examples of such compounds include polyalkylene glycols such as polypropylene glycol, thioether compounds described in JP-A-2-115260, and compounds having a mercapto group described in JP-A-6-166807. JP-A-8-225732, JP-A-8-225733, JP-A-8-225
No. 734, benzyl ethers, ethers having a benzyloxy structure such as benzyl alcohol, alcohol compounds, and sulfur compounds having a benzylthio structure such as benzyl sulfide. The amount of these stabilizers used is 100% of polycarbonate resin.
It is usually used in the range of 0.001 to 15 parts by weight based on part by weight.
【0036】本発明のポリカ−ボネ−ト樹脂組成物に
は、本発明の効果を損なわない程度に、他の樹脂材料、
例えば、ポリエチレンテレフタレート、ポリブチレンテ
レフタレート、ポリエステルポリカーボネート、ポリア
リレート、シクロヘキサンジメタノールとテレフタル酸
及び/またはイソフタル酸とのポリエステルまたはポリ
エチレンテレフタレートとのコポリエステル等を混合し
て使用することができる。通常、ポリカ−ボネ−ト樹脂
組成物の透明性、物性等を考慮してポリカーボネート樹
脂100重量部に対して30重量部以下の量で用いられ
る。The polycarbonate resin composition of the present invention contains other resin materials and other components to such an extent that the effects of the present invention are not impaired.
For example, polyethylene terephthalate, polybutylene terephthalate, polyester polycarbonate, polyarylate, a polyester of cyclohexane dimethanol with terephthalic acid and / or isophthalic acid, a copolyester of polyethylene terephthalate, or the like can be used as a mixture. Usually, it is used in an amount of 30 parts by weight or less with respect to 100 parts by weight of the polycarbonate resin in consideration of the transparency and physical properties of the polycarbonate resin composition.
【0037】本発明のポリカ−ボネ−ト樹脂組成物に
は、ポリカーボネート樹脂に対して通常用いられている
各種添加剤、例えば、成形性を改良するためにステアリ
ン酸、パルミチン酸等の高級脂肪酸とグリセリン、トリ
メチロールプロパン、ペンタエリスリトール等のアルコ
ールとのエステルまたは部分エステル、パラフィン等の
離型剤、リン酸エステル、亜リン酸エステル等の熱安定
剤、ヒンダードフェノール等の酸化防止剤のほか、耐候
性改良剤、紫外線吸収剤、難燃剤、難燃助剤、耐衝撃改
良剤、帯電防止剤、可塑剤、滑剤、相溶化剤、発砲剤、
補強剤、充填剤、染料、顔料等の着色剤等を、電離放射
線照射による悪影響が現れない範囲で配合させることが
できる。The polycarbonate resin composition of the present invention contains various additives generally used for polycarbonate resins, for example, higher fatty acids such as stearic acid and palmitic acid for improving the moldability. Glycerin, trimethylolpropane, esters or partial esters with alcohols such as pentaerythritol, release agents such as paraffin, heat stabilizers such as phosphate esters and phosphites, and antioxidants such as hindered phenols, Weather resistance improver, ultraviolet absorber, flame retardant, flame retardant auxiliary, impact resistance improver, antistatic agent, plasticizer, lubricant, compatibilizer, foaming agent,
Reinforcing agents, fillers, coloring agents such as dyes and pigments, and the like can be compounded within a range that does not adversely affect irradiation with ionizing radiation.
【0038】本発明のポリカ−ボネ−ト樹脂組成物は、
射出成形、押出成形、ブロ−成形、圧縮成形、トランス
ファ成形等通常用いられるいずれの成形法でも適用する
ことができる。なかでも、射出成形法が好ましく用いら
れ、ポリカ−ボネ−ト樹脂の種類、重合度、前記アセタ
ール化合物の種類、配合量、その他の添加剤の種類、量
等により変化するため一概には云えないが、通常、26
0〜350℃で成形される。The polycarbonate resin composition of the present invention comprises:
Any of commonly used molding methods such as injection molding, extrusion molding, blow molding, compression molding, transfer molding and the like can be applied. Among them, the injection molding method is preferably used, and it cannot be said unconditionally because it varies depending on the type of the polycarbonate resin, the degree of polymerization, the type and the amount of the acetal compound, the type and the amount of other additives, and the like. But usually 26
Molded at 0-350 ° C.
【0039】かくして得られる成形物は、電子線、γ
線、α線、中性子線、X線等の電離放射線に対して高い
安定性を有しており、特に、γ線又は電子線を滅菌用と
して用いる医療用器具の部材に適している。The molded product thus obtained is obtained by using an electron beam, γ
It has high stability against ionizing radiation such as X-rays, α-rays, neutron rays, and X-rays, and is particularly suitable for members of medical instruments that use γ-rays or electron beams for sterilization.
【0040】かかる医療器具の部材としては、人工透析
器(人工腎臓用ケ−ス、キャップ)、人工肺、麻酔用吸
入装置、静脈用コネクタ及び付属品、血液遠心分離ボウ
ル、外科用具、手術室用具、酸素を血液に供給するチュ
−ブ、チュ−ブの接続具、心臓プロ−ブ並びに注射器、
外科用具、手術室器具、静脈注射液などを入れる容器な
どが挙げられる。The members of such medical instruments include artificial dialysers (cases and caps for artificial kidneys), artificial lungs, anesthesia inhalers, intravenous connectors and accessories, blood centrifuge bowls, surgical tools, operating rooms Utensils, tubes for supplying oxygen to the blood, tube connections, heart probes and syringes,
Examples include surgical tools, operating room instruments, containers for storing intravenous injections, and the like.
【0041】[0041]
【実施例】以下に実施例により本発明を更に詳しく説明
するが、もとよりそれに限定されるものではない。実施
例中、部、%は特に断らない限り重量基準を意味する。The present invention will be described in more detail with reference to the following examples, but it should not be construed that the invention is limited thereto. In Examples, parts and percentages are by weight unless otherwise specified.
【0042】[アセタール化合物の合成]ベンズアルデ
ヒド212.2g(2.0mol)、ペンタエリスリト
ール136.1g(1.0mol)、トルエン600m
lをマグネティックスターラー、ディーンスターク、還
流冷却器を備えた1lのナスフラスコに入れ、p−トル
エンスルホン酸−1水和物3.8g(0.02mol)
を添加した。次にトルエン還流まで加熱し、6時間反応
させた後、3時間かけてトルエン300mlを留去し
た。室温まで冷却した後、塩化メチレンを加えて析出し
た無色固体を溶解し、中性になるまで水洗した。溶媒を
留去した後、得られた無色固体をエタノール/塩化メチ
レン混合液から再結晶して、3,9−ジフェニル−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン(前記式(1)で、mおよびnは0の化合物)273
g(収率88%)を無色鱗片状結晶として得た(融点:
159〜160℃)。化合物の同定は、1H−NMRス
ペクトル、IRスペクトルを用いて行った。[Synthesis of Acetal Compound] 212.2 g (2.0 mol) of benzaldehyde, 136.1 g (1.0 mol) of pentaerythritol, 600 m of toluene
l into a 1-liter eggplant flask equipped with a magnetic stirrer, Dean Stark, and a reflux condenser, and 3.8 g (0.02 mol) of p-toluenesulfonic acid monohydrate was added.
Was added. Next, the mixture was heated to reflux of toluene and reacted for 6 hours, and then 300 ml of toluene was distilled off over 3 hours. After cooling to room temperature, methylene chloride was added to dissolve the precipitated colorless solid and washed with water until neutral. After evaporating the solvent, the obtained colorless solid was recrystallized from a mixed solution of ethanol / methylene chloride to give 3,9-diphenyl-2,
4,8,10-Tetraoxaspiro [5,5] undecane (compound in the above formula (1), wherein m and n are 0) 273
g (88% yield) as colorless scaly crystals (melting point:
159-160 ° C). The compound was identified using a 1 H-NMR spectrum and an IR spectrum.
【0043】また、ベンズアルデヒドに代えて、相当の
化合物を使用して、同様に合成し、下記の化合物を得
た。 3,9−ビス(3−メチルフェニル)−2,4,8,
10−テトラオキサスピロ[5,5]ウンデカン(前記
式(1)で、mおよびnは1、R1およびR2はメチルの
化合物) 3,9−ビス(2,4−ジメチルフェニル)−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン(前記式(1)で、mおよびnは2、R1およびR2は
メチルの化合物) 3,9−ビス(4−iso−ブチルフェニル)−2,
4,8,10−テトラオキサスピロ[5,5]ウンデカ
ン(前記式(1)で、mおよびnは1、R1およびR2は
iso−ブチルの化合物) 3,9−ビス(4−フェニルフェニル)−2,4,
8,10−テトラオキサスピロ[5,5]ウンデカン
(前記式(1)で、mおよびnは1、R1およびR2はフ
ェニルの化合物)In addition, a similar compound was used in place of benzaldehyde and synthesized in the same manner to obtain the following compound. 3,9-bis (3-methylphenyl) -2,4,8,
10-tetraoxaspiro [5,5] undecane (in the formula (1), m and n are 1, R 1 and R 2 are methyl compounds) 3,9-bis (2,4-dimethylphenyl) -2 ,
4,8,10-tetraoxaspiro [5,5] undecane (in the above formula (1), m and n are 2, R 1 and R 2 are methyl compounds) 3,9-bis (4-iso-butyl) Phenyl) -2,
4,8,10-tetraoxaspiro [5,5] undecane (in the above formula (1), m and n are 1, R 1 and R 2 are iso-butyl compounds) 3,9-bis (4-phenyl) Phenyl) -2,4,
8,10-tetraoxaspiro [5,5] undecane (in the above formula (1), m and n are 1, R 1 and R 2 are phenyl compounds)
【0044】[実施例1〜5]ビスフェノールA型のポ
リカーボネート樹脂(帝人化成(株)製パンライトL−
1225)100部に対して表1記載の各種アセタール
化合物を表1記載の量添加し、φ30mm一軸ベント式
押出機を用いて、バレル温度260〜280℃で溶融押
出してペレットを得た。このペレットを熱風乾燥機中
で、120℃にて5時間以上乾燥した後、シリンダー温
度280〜300℃で射出成形して、2mm厚の透明試
験片を作成した。この試験片を用い、コバルト60γ線
を25キログレイ(kGy)照射した。脱酸素中の場合
は、この透明試験片と共に市販の脱酸素剤を袋に封入し
たものに対して照射を行った。照射前後の黄色度(ΔY
I)を、JIS K7103に従って測定した。結果を
表1に示した。Examples 1 to 5 Bisphenol A type polycarbonate resin (Panlite L-manufactured by Teijin Chemicals Ltd.)
1225) To 100 parts of the various acetal compounds shown in Table 1 were added in the amounts shown in Table 1 and melt-extruded at a barrel temperature of 260 to 280 ° C. using a φ30 mm uniaxial vent type extruder to obtain pellets. The pellets were dried in a hot air drier at 120 ° C. for 5 hours or more, and then injection molded at a cylinder temperature of 280 to 300 ° C. to produce a 2 mm thick transparent test piece. Using this test piece, cobalt 60γ ray was irradiated with 25 kilogray (kGy). During the deoxidation, irradiation was performed on the transparent test piece sealed in a bag with a commercially available deoxidizer. Yellowness before and after irradiation (ΔY
I) was measured according to JIS K7103. The results are shown in Table 1.
【0045】[参照例1]アセタール化合物を用いない
こと以外は実施例1と同様にしてポリカーボネート樹脂
の透明試験片を作成し、この試験片を用いてγ線照射前
後の黄変度(ΔYI)を求めた。結果を表1に示した。Reference Example 1 A transparent test piece of a polycarbonate resin was prepared in the same manner as in Example 1 except that no acetal compound was used, and the yellowing degree (ΔYI) before and after γ-ray irradiation was prepared using this test piece. I asked. The results are shown in Table 1.
【0046】[0046]
【表1】 [Table 1]
【0047】[0047]
【発明の効果】本発明のポリカーボネート樹脂組成物
は、物性の劣化が少なく滅菌のために照射される電離放
射線による色調の変化が少ない。従って、電離放射線処
理が行われる医療用製品、医療用装置の部材等の用途に
極めて有用である。Industrial Applicability The polycarbonate resin composition of the present invention has little deterioration in physical properties and little change in color tone due to ionizing radiation irradiated for sterilization. Therefore, it is extremely useful for applications such as medical products to be subjected to ionizing radiation treatment and members of medical devices.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 畠中 邦夫 東京都千代田区内幸町1丁目2番2号 帝 人化成株式会社内 Fターム(参考) 4C081 AC01 AC06 AC08 AC09 AC11 AC15 BB03 CA201 CC01 DA03 4J002 CG011 CG021 CG031 EL126 FD036 GB01 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Kunio Hatanaka 1-2-2 Uchisaiwaicho, Chiyoda-ku, Tokyo F-term in Teijin Chemicals Limited (reference) 4C081 AC01 AC06 AC08 AC09 AC11 AC15 BB03 CA201 CC01 DA03 4J002 CG011 CG021 CG031 EL126 FD036 GB01
Claims (3)
び下記式(1)で示されるアセタール化合物0.001
〜20重量部からなる電離放射線安定化ポリカーボネー
ト樹脂組成物。 【化1】 (式中、mおよびnは0〜5の整数であり、R1および
R2は、それぞれ同一でも異なっていてもよく、炭素数
1〜18の炭化水素基、炭素数1〜18の炭化水素オキ
シ基、炭素数1〜18のアシル基、炭素数1〜18のア
シロキシ基および炭素数2〜8のポリオキシ炭化水素基
からなる群より選ばれる少なくとも1つの基を示す。)1. 100 parts by weight of a polycarbonate resin and 0.001 of an acetal compound represented by the following formula (1):
An ionizing radiation-stabilized polycarbonate resin composition comprising up to 20 parts by weight. Embedded image (In the formula, m and n are integers of 0 to 5, R 1 and R 2 may be the same or different, and each may be a hydrocarbon group having 1 to 18 carbon atoms, a hydrocarbon group having 1 to 18 carbon atoms. It represents at least one group selected from the group consisting of an oxy group, an acyl group having 1 to 18 carbon atoms, an acyloxy group having 1 to 18 carbon atoms, and a polyoxyhydrocarbon group having 2 to 8 carbon atoms.)
して、前記式(1)で示されるアセタール化合物が0.
01〜5重量部である請求項1記載の電離放射線安定化
ポリカーボネート樹脂組成物。2. An acetal compound represented by the formula (1) is added in an amount of 0.1 to 100 parts by weight of a polycarbonate resin.
The ionizing radiation-stabilized polycarbonate resin composition according to claim 1, wherein the amount is from 01 to 5 parts by weight.
び前記式(1)で示されるアセタール化合物0.001
〜20重量部からなる医療用器具の部材用ポリカーボネ
ート樹脂組成物。3. 100 parts by weight of a polycarbonate resin and 0.001 of an acetal compound represented by the formula (1).
A polycarbonate resin composition for a member of a medical device, comprising up to 20 parts by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000083984A JP2001270980A (en) | 2000-03-24 | 2000-03-24 | Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000083984A JP2001270980A (en) | 2000-03-24 | 2000-03-24 | Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001270980A true JP2001270980A (en) | 2001-10-02 |
Family
ID=18600530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000083984A Pending JP2001270980A (en) | 2000-03-24 | 2000-03-24 | Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001270980A (en) |
-
2000
- 2000-03-24 JP JP2000083984A patent/JP2001270980A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050113535A1 (en) | Ionizing radiation stable polyarylestercarbonate compositions | |
JP2001294690A (en) | Method for sterilizing polycarbonate resin molded product | |
JP2001270982A (en) | Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment | |
JP2001270980A (en) | Ionizing radiation stabilized polycarbonate resin composition and polycarbonate resin composition for part of medical equipment | |
JP3330793B2 (en) | Polycarbonate resin composition | |
JP2001072851A (en) | Polycarbonate resin composition resistant to ionizing radiation and polycarbonate resin composition for member of medical treatment appliance | |
CN107922725B (en) | Ionizing radiation resistant polycarbonate resin composition and molded product comprising the same | |
JPH0940854A (en) | Polycarbonate resin composition | |
JPH09310010A (en) | Polycarbonate resin composition | |
JP3592844B2 (en) | Polycarbonate resin composition | |
JP3592843B2 (en) | Polycarbonate resin composition | |
JP2002069283A (en) | Polycarbonate resin composition | |
JP2001072848A (en) | Polycarbonate resin composition resistant to ionizing radiation and polycarbonate resin composition for members of medical treatment appliances | |
JP3335800B2 (en) | Polycarbonate resin composition | |
JPH04339857A (en) | Polyester-carbonate composition resistant to gamma ray | |
JP3618444B2 (en) | Polycarbonate resin composition | |
JP3370219B2 (en) | Polycarbonate resin composition | |
JPH10324797A (en) | Polycarbonate resin composition | |
JPS63213556A (en) | Ultraviolet ray stabilized blend of polycarbonate resin and copolymer reformer | |
JPH10259298A (en) | Polycarbonate resin composition | |
JP3618459B2 (en) | Polycarbonate resin composition | |
JPH08311324A (en) | Polycarbonate resin composition | |
JP3618458B2 (en) | Polycarbonate resin composition | |
JPH0959504A (en) | Polycarbonate resin composition | |
JPH06145491A (en) | Polycarbonate resin composition |